Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Dibotatug in Adults With Bone Marrow Failure Syndromes

This is a multicenter, open-label, Phase 1/2 basket study to evaluate the safety and efficacy of Dibotatug (DR-01) in adults with Bone Marrow Failure syndromes.

Bone Marrow Failure SyndromesAplastic AnemiasSevere Aplastic Anemia (SAA)+3 more

Estimated

~$10 – $7,500

Dren BioNCT07712562